Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

46.92
Delayed Data
As of Sep 23
 -1.07 / -2.23%
Today’s Change
30.93
Today|||52-Week Range
54.96
+22.96%
Year-to-Date
Ligand Inks CNS License Agreement with Seelos Therapeutics
Sep 23 / Zacks.com - Paid Partner Content
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
Sep 21 / Zacks.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
The Medicines Co. to Get BARDA Funding for Infection Drugs
Sep 22 / Zacks.com - Paid Partner Content
Vical Slumps, Cytomegalovirus Vaccine Fails in Phase II Study
Sep 20 / Zacks.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
BioDelivery Bunavail Gets Better Managed Care Positioning
Sep 20 / Zacks.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Strives for Increased Sales & Earnings Growth
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close47.99
Today’s open47.69
Day’s range46.62 - 47.91
Volume113,605
Average volume (3 months)125,793
Market cap$693.4M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)-0.66%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-11.93%
P/E ratio20.5
Price/Sales6.29
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
KTWOK2M Group Holdings I...-0.24-1.37%
ANGOAngioDynamics Inc-0.10-0.57%
CERSCerus Corp-0.02-0.32%
CSIICardiovascular Syste...-0.66-2.79%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts

Search for Jobs